CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Current Features

Designing Quality into the Process: Integrating QbD and PAT for Modern Drug Delivery

Pharmaceutical quality is built on the principle that medicines are manufactured to be consistent and released in accordance with defined specifications. And while t...
Continue Reading →
Current Features

Global Approaches to Oral Drug Administration Using Enteral Feeding Tubes: A Review of FDA and EMA Guidance

Enteral feeding tubes (EFTs) are essential to use in cases where patients are unable to swallow oral dosage forms due to conditions such as dysphagia, neurological d...
Continue Reading →
Current Features

Plastic Pre-filled Syringes: Clinical Advantages, Technical Requirements, and Material Selection Criteria

In the last decade, the use of plastic pre- filled syringes for parenteral administration has been steadily growing. In fact, the compound annual growth rate (CAGR) ...
Continue Reading →
Current Features

What the Injectables Surge Is Really Asking of Pharmaceutical Packaging

The scale of the GLP-1 market is well understood by anyone working in pharmaceutical manufacturing. Semaglutide and tirzepatide, at least in the context of weight lo...
Continue Reading →
Current Features

From Clinical Waste to Clinical Grade: Validating Circularity in Healthcare Plastics

One of the greatest barriers to circularity in healthcare plastics has not been collection or recycling alone, but proof. In regulated healthcare applications, it is...
Continue Reading →
Current Features

Packaging as a Driver of Patient Adherence in Ophthalmic Therapy

Why usability, safety and evolving regulation are reshaping preservativefree eye care In ophthalmic therapy, the package is no longer a passive container. It has...
Continue Reading →
Current Features

Why AI, Counterfeit Medicines, and Fake Trust Signals Are Creating a Clone Pharmacy Crisis

These days, a patient searching online for weight management treatment might come across two websites that look equally legitimate. One may belong to a regulated pha...
Continue Reading →
Current Features

Why CMC Development Requires a Systems Re-think

Pharmaceutical development generates huge amounts of analytical data and metadata, but volume is not the core problem. The real challenge is data fragmentation. The ...
Continue Reading →
Current Features

Real-Time LCA: From Sustainability Reporting to Sustainable Action

Though pharmaceutical organisations have more sustainability data than ever before, the value of this data often remains limited to one-off reporting exercises, rath...
Continue Reading →
Current Features

Expert Roundtable: Navigating the Next Phase of Low Carbon pMDI Development

In May 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the world's first low carbon pressurised Metered Dose Inhaler (pMDI). For an...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026